A novel lonidamine derivative targeting mitochondria to eliminate cancer stem cells by blocking glutamine metabolism
Qiang Wang(General Hospital of Jinan Military Command), Zifu Li(Medical Protective), Tian Yang(Second Military Medical University), Ao Hua(Huazhong University of Science and Technology), Shiyou Li(Temple College), Zeyang Ding(Huazhong University of Science and Technology), Bixiang Zhang(Ministry of Education of the People's Republic of China), Xiang Chen(Zhejiang Sci-Tech University), Chong Wang(South China Agricultural University), Chen Xu(Chinese Academy of Medical Sciences & Peking Union Medical College), Jiangling Wan(Huazhong University of Science and Technology), Yuxuan Xiong(Huazhong University of Science and Technology), Qingyuan Deng(Shihezi University), Xiangliang Yang(Medical Protective)
Cited by 27
Related Papers
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2014|1.4k
Novel mutations target distinct subgroups of medulloblastoma
|Nature|2012|853
Tumor exosome-based nanoparticles are efficient drug carriers for chemotherapy
|Nature Communications|2019|803